جميع الدراسات
التوظيفرَصْدِيّ

Observational SIR-Spheres Study for the Treatment of Unresectable Liver Tumors (SIRtain Registry)

This study, called the SIRtain Registry, is looking at a treatment called SIR-Spheres for liver tumours that doctors can't remove with surgery. This includes certain liver cancers (hepatocellular carcinoma) and liver tumours that have spread from bowel cancer, especially if other treatments like chemotherapy haven't worked or can't be used. Instead of testing a new drug, this study simply gathers information from many hospitals around the world about how SIR-Spheres is used in real life. The main goal is to understand how well the treatment helps patients and to confirm it's being used safely and effectively. It’s about watching and learning from patients who are already receiving this treatment as part of their usual care.

نظرة سريعة

الحالة
التوظيف
الراعي
Sirtex Medical
الهدف من التسجيل
845
ابدأ
19 يونيو 2023
التاريخ المتوقع للانتهاء
01 Jun 2029

ما هو موضوع هذه الدراسة؟

This study is gathering information about a treatment for liver tumours called SIR-Spheres. These are tiny radioactive beads that are delivered directly to the liver to treat tumours that can't be removed by surgery. This could be liver cancer that started in the liver (called hepatocellular carcinoma) or tumours that have spread to the liver from bowel cancer.

The study isn't testing a new medicine or asking people to try something experimental. Instead, it's like a big information-gathering project. Doctors from many different hospitals in several countries will share details about patients who are already receiving SIR-Spheres as part of their regular treatment plan. They want to see how the treatment works for these patients in real-world situations, rather than in a special trial setting.

The main aim is to build a clearer picture of how effective SIR-Spheres is and to make sure it's being used correctly and safely for people with these types of liver tumours. By looking at information from a large number of patients, they hope to learn more about the best ways to use this treatment.

النقاط الرئيسية

  • This study collects information about an existing liver tumour treatment called SIR-Spheres.
  • It's for people with liver tumours that can't be removed by surgery, including some liver cancers or tumours spread from bowel cancer.
  • The study observes how SIR-Spheres performs in real-world settings, not a new experimental drug.
  • Participation involves sharing medical information from your regular care; no extra tests or visits.
  • You must be 18 or older and your doctor must have already decided SIR-Spheres is right for you.
  • You can withdraw from the study at any time without affecting your medical treatment.

من قد يكون مؤهلاً؟

To be part of this study, you need to be at least 18 years old. You must have a confirmed diagnosis of liver cancer that can't be surgically removed, or liver tumours that have spread from bowel cancer and haven't responded well to chemotherapy or you can't have chemotherapy.

Crucially, your doctor must have already decided that SIR-Spheres treatment is the right option for you, and it must be your first time receiving this specific treatment for your liver. You also need to be able to understand the study and agree to take part yourself. If someone else would need to give permission for you, you unfortunately can't join.

You cannot join if you've previously had radiation treatment to your liver or if you're already participating in another clinical trial that involves an experimental medicine or procedure.

هل يمكن أن تناسبك هذه الدراسة؟

أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.

  1. هل عمرك 18 سنة أو أكثر؟
  2. Do you have liver tumours that doctors can't remove with surgery (either liver cancer or tumours spread from bowel cancer)?
  3. Have other treatments, like chemotherapy, not worked or are not suitable for you?
  4. Has your doctor already recommended SIR-Spheres as your treatment?
  5. Is this your first time receiving SIR-Spheres for your liver?
  6. Have you NOT had radiation treatment to your liver before?
أجب عن كل سؤال لترى نتيجتك.

ماذا يتضمن المشاركة؟

If you join this study, it means that information about your treatment with SIR-Spheres will be collected. You won't be given any extra medicines or asked to have any additional tests just for the study. Instead, the doctors will simply record details about your health, your treatment, and how you respond to it, as part of your normal medical care. This information will be gathered for research purposes, helping to understand the treatment better. The total duration of your participation will depend on your individual treatment plan and follow-up, as determined by your doctor.

المخاطر والفوائد المحتملة

The potential benefit of taking part is that your information will contribute to a better understanding of SIR-Spheres, which could help future patients. You won't be receiving a new, untested treatment, as SIR-Spheres is already an approved therapy. As this is an observational study, you won't face additional risks beyond those associated with your standard medical care and the SIR-Spheres treatment itself. You are always in control and have the right to withdraw your consent and stop participating in the study at any time, without it affecting your medical care.

المواقع (9)

  • مستشفى بوجون
    الرمز البريدي المؤكد
    كليشي، فرنسا· التوظيف
  • Hopital Henri Mondor
    الرمز البريدي المؤكد
    كريتاي، فرنسا· لم يبدأ التوظيف بعد
  • Hospices Civils de Lyon HCL Centre Hospitalier Lyon-Sud
    الرمز البريدي المؤكد
    بيير بينيت، فرنسا· التوظيف
  • Hospital Universitario Puerta de Hierro - Majadahonda
    الرمز البريدي المؤكد
    Majadahonda, Spain· لم يبدأ التوظيف بعد
  • Hospital General Universitario Gregorio Marañon
    الرمز البريدي المؤكد
    مدريد، إسبانيا· لم يبدأ التوظيف بعد
  • Hospital Clinico Universitario de Valencia
    الرمز البريدي المؤكد
    فالنسيا، إسبانيا· لم يبدأ التوظيف بعد
  • مستشفى كريستي
    الرمز البريدي المؤكد
    مانشستر، المملكة المتحدة· لم يبدأ التوظيف بعد
  • Kings College Hospital
    الرمز البريدي المؤكد
    لندن، المملكة المتحدة· لم يبدأ التوظيف بعد
  • مستشفى هامرسميث
    الرمز البريدي المؤكد
    لندن، المملكة المتحدة· لم يبدأ التوظيف بعد

أسئلة شائعة

What is SIR-Spheres?

SIR-Spheres are tiny radioactive beads that are used to treat liver tumours by delivering radiation directly to the tumour.

Is this a typical clinical trial where I take a new drug?

No, this isn't a trial testing a new drug. It's an 'observational study' which means doctors are simply collecting information about how an existing treatment (SIR-Spheres) works for patients in real life.

Will I have extra doctor visits if I join?

No, you won't need any extra doctor visits or tests specifically for this study. All the information gathered will be from your regular medical appointments.

من يمكنه الانضمام إلى هذه الدراسة؟

Adults (18+) with certain types of liver tumours that can't be removed by surgery, who are having SIR-Spheres for the first time, and haven't had liver radiation before.

هل يمكنني التوقف عن المشاركة في الدراسة إذا غيرت رأيي؟

Yes, absolutely. You can decide to stop participating at any time, and it won't affect your medical care.

كيفية معرفة المزيد

Janet Bell

تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.

هل أنت مهتم بالمشاركة؟

سجل اهتمامك

شارك تفاصيلك وفريق البحث لـ "Observational SIR-Spheres Study for the Treatment of Unresec… "سيتواصل معك إذا كنت مؤهلاً. تحدث دائمًا إلى طبيبك قبل الموافقة على المشاركة.

نقاش

مناقشة المجتمع

مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.